Why is Eiko Lifescience falling/rising?

As of 21-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 54.73, which reflects a decrease of Rs 2.75 or 4.78%. The stock has underperformed its sector by 5.64% today, having touched an intraday low of Rs 54, indicating a significant drop of 6.05%. Over the past week, the stock has decreased by 3.37%, while it has shown a positive return of 10.10% over the last month. However, the stock's year-to-date performance is notably poor, with a decline of 12.77%. Despite some positive indicators such as rising promoter confidence, with a 4.96% increase in their stake, the company is facing challenges, including weak long-term fundamentals evidenced by a low average Return on Equity (ROE) of 2.82% and a significant drop in net sales.
In the broader market context, the Sensex has remained relatively stable with a slight decrease of 0.06% over the past week, contrasting with Eiko Lifesciences' more pronounced decline. This suggests that the stock's poor performance is not solely due to broader market trends but is influenced by company-specific issues. The stock's long-term performance has also been underwhelming, with a 16.70% decline over the past year, which is compounded by flat quarterly results and an expensive valuation relative to its peers. Overall, while there are some positive signs such as increased promoter confidence, the negative factors, including weak financial performance and underperformance against benchmarks, contribute to the stock's current downward trajectory.